150 related items for PubMed ID: 2559616
21. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
Loras B, Roux H, Audi-Parera L, David M, Bertrand J.
Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
[No Abstract] [Full Text] [Related]
22. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
[Abstract] [Full Text] [Related]
23. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia.
Spritzer P, Billaud L, Thalabard JC, Birman P, Mowszowicz I, Raux-Demay MC, Clair F, Kuttenn F, Mauvais-Jarvis P.
J Clin Endocrinol Metab; 1990 Mar 25; 70(3):642-6. PubMed ID: 2137832
[Abstract] [Full Text] [Related]
24. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
Hansen JW, Loriaux DL.
Pediatrics; 1976 Jun 25; 57(6):942-7. PubMed ID: 934750
[Abstract] [Full Text] [Related]
25. Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia.
Ciaccio M, Montiveros C, Rivarola MA, Belgorosky A.
Medicina (B Aires); 2002 Jun 25; 62(6):551-4. PubMed ID: 12532689
[Abstract] [Full Text] [Related]
26. Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty.
Beyer J, Demisch K, Wiegelmann W, Happ J, Kollmann F, Schöffling K.
Acta Endocrinol Suppl (Copenh); 1973 Jun 25; 173():169. PubMed ID: 4542094
[No Abstract] [Full Text] [Related]
27. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Hochberg Z, Benderly A, Kahana L, Zadik Z.
J Clin Endocrinol Metab; 1986 Jul 25; 63(1):36-40. PubMed ID: 3011843
[Abstract] [Full Text] [Related]
28. [Growth and puberal development in males with adreno-genital syndrome].
Gargantini L, Calzi P, Brunelli V, Braggion F, Chiumello G.
Pediatr Med Chir; 1989 Jul 25; 11(6):597-602. PubMed ID: 2699925
[Abstract] [Full Text] [Related]
29. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
J Pediatr; 2015 Mar 25; 166(3):743-50. PubMed ID: 25557963
[Abstract] [Full Text] [Related]
30. [Clinical use of cyproterone acetate in children].
Helge H, Korth-Schütz S.
Gynakologe; 1980 Mar 25; 13(1):44-53. PubMed ID: 6219929
[No Abstract] [Full Text] [Related]
31. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
Ahmed SEAM, Soliman AT, Ramadan MA, Elawwa A, Abugabal AMS, Emam MHA, De Sanctis V.
Acta Biomed; 2019 Sep 06; 90(3):360-369. PubMed ID: 31580328
[Abstract] [Full Text] [Related]
32. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth.
Rivkees SA, Crawford JD.
Pediatrics; 2000 Oct 06; 106(4):767-73. PubMed ID: 11015521
[Abstract] [Full Text] [Related]
33. [Hydrocortisone therapy of the AGS (adrenogenital syndrome)].
Rager K, Huenges R, Bierich JR, Gupta D.
Monatsschr Kinderheilkd (1902); 1973 Jul 06; 121(7):411-2. PubMed ID: 4751478
[No Abstract] [Full Text] [Related]
34. Elevation of serum luteinizing hormone levels during hydrocortisone treatment in infant girls with 21-hydroxylase deficiency.
Belgorosky A, Chahin S, Rivarola MA.
Acta Paediatr; 1996 Oct 06; 85(10):1172-5. PubMed ID: 8922078
[Abstract] [Full Text] [Related]
35. A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.
Laue L, Merke DP, Jones JV, Barnes KM, Hill S, Cutler GB.
J Clin Endocrinol Metab; 1996 Oct 06; 81(10):3535-9. PubMed ID: 8855797
[Abstract] [Full Text] [Related]
36. The effect of different treatment regimens on hormonal profiles in congenital adrenal hyperplasia.
Smith R, Donald RA, Espiner EA, Glatthaar C, Abbott G, Scandrett M.
J Clin Endocrinol Metab; 1980 Aug 06; 51(2):230-6. PubMed ID: 6249832
[No Abstract] [Full Text] [Related]
37. [A review of 74 cases of precocious puberty treated with cyproterone acetate in Japan (author's transl)].
Koshimizu T, Kato K, Shimizu N, Hibi I, Suwa S.
Nihon Naibunpi Gakkai Zasshi; 1981 Jan 20; 57(1):42-63. PubMed ID: 6453732
[No Abstract] [Full Text] [Related]
38. [Growth in congenital adrenal hyperplasia].
Gussinye M, García-Horlich S, Vicens-Calvet E, Carrascosa A.
An Esp Pediatr; 1992 Jun 20; 36 Suppl 50():101-4. PubMed ID: 1329595
[No Abstract] [Full Text] [Related]
39. Gonadal dysfunction in adult men with congenital adrenal hyperplasia.
Moore GW, Lacroix A, Rabin D, McKenna TJ.
Acta Endocrinol (Copenh); 1980 Oct 20; 95(2):185-93. PubMed ID: 6254306
[Abstract] [Full Text] [Related]
40. Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
Bailey CC, Komrower GM.
Arch Dis Child; 1974 Jan 20; 49(1):4-7. PubMed ID: 4361889
[No Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
